Amita Risbud
Endocrinology, Diabetes & Metabolism Physician · San Francisco, CA
Amita Risbud is an endocrinology, diabetes & metabolism physician with a practice address in San Francisco, California, and NPI 1194353490, issued on Mar 31, 2020. Check the license (California A187144, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Amita Risbud
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- A187144 CA
Self-reported in NPPES; status is on the state search - Practice location
- 1100 Van Ness Ave, San Francisco, CA 94109
- Phone
- (415) 600-0110
- Enumerated
- Mar 31, 2020
- Record last updated
- Sep 22, 2025
- Fax
- (415) 558-7038
- Medicare enrollment
- Enrolled (PECOS I20251014001379); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 1,131 in California → Look up another NPI →
Also registered at 1100 Van Ness Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Anousheh Afjei, MDInternal Medicine Physician1992365431
- Mohammed Ahmed, MDInternal Medicine Physician1700245115
- Haila AlbgalFamily Nurse Practitioner1417566043
- Ashley Arnold, LCSWClinical Social Worker1710559687
- Anjali Asrani, NPNurse Practitioner1184279770
- Ginny BaoEndocrinology, Diabetes & Metabolism Physician1801383286
Verify Amita Risbud in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A187144Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
84% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
421 Medicare Part D claims for 89 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 60% of claims.
Most prescribed
- Ozempic81 claims
- Levothyroxine Sodium43 claims
- Mounjaro19 claims
- Atorvastatin Calcium18 claims
- Metformin Hcl18 claims
- Jardiance17 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Sutter Bay Medical FoundationSan Francisco, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Amita Risbud among 1,131 endocrinology, diabetes & metabolism physician records in California
Amita Risbud is one of 1,131 endocrinology, diabetes & metabolism physician records with a practice address in California. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 96% of them.
- NPI issued2020 · 96% of these records are older, 2% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 69% of these records are
- Graduated2020 · median 2003 among the 779 with a school on file
- Record last updated2025 · 57% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in California
There are 1,131 endocrinology, diabetes & metabolism physician records in California.
All 1,131 in California → Every provider in San Francisco → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Diana Antoniucci, MDSan Francisco, CA 941091164486676
- Wade Aubry, M.DSan Francisco, CA 941091447265814
- Ginny BaoSan Francisco, CA 941091801383286
- Kjersti Kirkeby, M.D.San Francisco, CA 941091811182454
- Hanna Rifkin, RDSan Francisco, CA 941091093225443
- Christina Ryu, M.D.San Francisco, CA 941091518491158
- Ashlee Sidhu, MBBSSan Francisco, CA 941091538746078
- Melissa Weinberg, M.D.San Francisco, CA 941091659399079
Common questions
What is Amita Risbud's NPI number?
Amita Risbud's National Provider Identifier (NPI) is 1194353490, issued on Mar 31, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Amita Risbud located?
The NPPES record lists a practice address at 1100 Van Ness Ave, San Francisco, CA, 94109. Phone: (415) 600-0110. Providers update this record themselves, so call before visiting.
How can I verify Amita Risbud's license?
NPPES lists California license number A187144, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Amita Risbud prescribe under Medicare Part D?
In 2024, Amita Risbud had 421 Medicare Part D claims for 89 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.